Your Cart is Empty
Start shopping
STYLAGE® M BI-FLEX® with Lidocaine
$169.00
/unitProduct details
- Brand:
- STYLAGE®
- Manufacturer:
- Vivacy
- Active Substance(s):
- CROSS-LINKED HYALURONIC ACID (HA), MANNITOL, LIDOCAINE
- Strength:
- 20mg/g HA, 9mg/ml Mannitol, 3mg/ml Lidocaine
- Pack size:
- 2 x 1ml Pre-Filled Syringes, 2 x 30 G ½ Needles
Product description
STYLAGE® M BI-FLEX® with Lidocaine is an injectable hyaluronic acid dermal filler using IPN-Like Technology™, formulated with 20mg/g HA, 9mg/mL mannitol, and 3mg/mL lidocaine. Manufactured by Laboratories VIVACY in France, it features a patented syringe system formerly known as Bi-SOFT® and is indicated for moderate wrinkle correction, volume restoration, and hand rejuvenation. Each pack contains 2 × 1mL prefilled syringes and 2 × 30G ½ needles. Are you looking to buy STYLAGE® M BI-FLEX® with Lidocaine online? Contact Doctor Medica’s staff for guidance on how to find qualified suppliers and supporting documentation.
Tier
| Packs | Discount (%) | For Each |
|---|---|---|
| 1 - 5 | — | $169.00 |
| 6 - 10 | 1.18 % | $167.00 |
| 11 - 20 | 2.37 % | $165.00 |
| 21+ | 2.96 % | $164.00 |
Shop with Confidence: Product Authenticity is Guaranteed
All products available at Doctor Medica shop are obtained from respective manufacturers and contain original LOT numbers Contact us if you have any questions about product LOT numbers.
FAQ
STYLAGE® M BI-FLEX® with Lidocaine is an injectable HA dermal filler manufactured by Laboratories VIVACY in France. It uses IPN-Like Technology™, BI-FLEX® rheology, and a patented syringe system formerly known as Bi-SOFT®. It contains 20mg/g HA, 9mg/mL mannitol, and 3mg/mL lidocaine. The STYLAGE® range is CE-marked for use in the EU, subject to local regulatory requirements.
STYLAGE® M BI-FLEX® with Lidocaine is used for moderate wrinkle correction, including nasolabial folds and marionette lines, as well as facial volume restoration, lip augmentation where appropriate, and hand rejuvenation. Use depends on treatment area, injection depth, tissue quality, local labeling, and practitioner assessment. It should be administered only by trained aesthetic professionals.
The patented syringe system, formerly known as Bi-SOFT®, is a delivery system developed by Laboratories VIVACY designed to support controlled, smooth injection and precise product placement during aesthetic procedures. It should be understood as a delivery feature, not as a substitute for injection training or anatomical expertise.
STYLAGE® products are CE-marked and clinically used in professional aesthetic medicine. The STYLAGE® M BI-FLEX® with Lidocaine formulation incorporates IPN-Like Technology™ for cohesivity, mannitol to support HA longevity, BI-FLEX® rheology for controlled injection across treatment areas, and a patented syringe system for precise delivery. Suitability for a specific patient or indication should be determined by practitioner assessment based on treatment area, anatomy, and clinical objectives.
The STYLAGE® range is CE-marked for use in the EU, but current US FDA status should be verified before procurement or use. FDA approval for dermal fillers is product- and indication-specific. Practitioners should confirm jurisdiction-specific regulatory status before clinical discussion, procurement, or administration.
Common side effects include swelling, redness, tenderness, bruising at the injection site, pain, itching, firmness, or mild nodularity. These commonly resolve within a few days. Worsening pain, change in skin color, blanching, livedo, or visual symptoms require urgent clinical evaluation.
Citations
- Mole B, Gozlan L. Benefits of adding lidocaine to a hyaluronic gel – Stylage® M. J Cosmet Laser Ther. 2011;13(5):249-254. doi:10.3109/14764172.2011.613478
- Stéphane S, Candice SM, Florence B. “Bi-Bi” technique for lip augmentation: A retrospective study on 30 cases. J Cosmet Dermatol. 2022;21(10):4339-4344. doi:10.1111/jocd.15221
- Ramos-E-Silva M, Fonteles LA, Lagalhard CS, Fucci-da-Costa AP. STYLAGE®: a range of hyaluronic acid dermal fillers containing mannitol. Physical properties and review of the literature. Clin Cosmet Investig Dermatol. 2013;6:257-261. Published 2013 Oct 23. doi:10.2147/CCID.S35251
For licensed medical professionals only. This content is for informational purposes only and does not constitute medical advice.
